Intelligence / B2B SaaS / Acquisitions / Nu-Med Plus, Inc.
M&Acompleted an acquisition (SEC 8-K)25 Aug 2026
Nu-Med Plus, Inc.
25 Aug 2026: Completed an acquisition (SEC 8-K) · Medical devices. Recorded in the SEC EDGAR full-text search.
- Filed
- 25 Aug 2026
- Ticker
- NUMD
- Role
- Completed an acquisition
- Sector
- Medical devices
- Sic
- 3841
- Items
- 1.01, 2.01, 3.02, 9.01
- Summary
- Net Smelter Returns Royalty Agreements In connection with the Closing, MGC entered into six Net Smelter Returns Royalty Agreements (collectively, the " Royalty Agreements ") pursuant to which MGC granted a 5.0% net smelter returns royalty with respect to each of the Properties as follows: a 5.0% net smelter returns roy
- Location
- Port Jefferson, NY
- State
- New York
- Country
- United States
- SEC CIK
- 1543637
- Reference
- 0001575872-26-000609
What this signal means
Integration means consolidating tools and vendors: the buyer re-platforms the target, and an acquired company's stack is reviewed by its new owner.
- Completed an acquisition leads with 189 of 292, then Sold assets or a business (82).
- 103 added in the 30 days to 19 Nov 2026.
Reach them with AOS
Find the decision makers at Nu-Med Plus, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this m&a signal, for your approval.
More in Completed an acquisition
Acquisitions
18 NovAI Era Corp.completed an acquisition (SEC 8-K) · Real estate and investmentM&A18 NovSoundthinking, INC.completed an acquisition (SEC 8-K) · Software and ITM&A17 NovGridAI Technologies Corp.completed an acquisition (SEC 8-K) · Energy and utilitiesM&A17 NovInteger Holdings Corpcompleted an acquisition (SEC 8-K) · Medical devicesM&A17 NovPacira BioSciences, Inc.completed an acquisition (SEC 8-K) · Pharma and biotechM&A17 NovViatris Inccompleted an acquisition (SEC 8-K) · Pharma and biotechM&A
Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 2.01 (completion of an acquisition or disposition of assets) filed with the SEC in the last 90 days. The role (buyer, company acquired, seller) is read from the filing's own wording, which is quoted on each row. AOS shows what the public record says; it does not verify or endorse the company.